From October 2025 through July 2026, I navigated the complex journey of recovery following a DVT that resulted in two pulmonary embolisms. This post outlines my experience and the multiphase conditioning protocol I developed to manage my recovery, with a specific focus on the unique physiological challenges of navigating the winter months.

1. Executive Summary & Overview

Recovery from Venous Thromboembolism (VTE), encompassing Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), is a protracted physiological process requiring structured clinical management and patient-led conditioning. While the acute phase focuses on stabilization via anticoagulation, long-term success is dictated by the mitigation of Post-Thrombotic Syndrome (PTS) and Post-PE Syndrome. Environmental factors, particularly cold weather, introduce specific hemodynamic challenges that must be integrated into any recovery protocol. This report outlines a multiphase conditioning strategy to restore cardiopulmonary function while addressing the risks of vascular strain.

2. Cold Weather Dynamics & Vascular/Pulmonary Strain

Cold exposure initiates a cascade of physiological responses that can complicate the recovery of VTE patients. Understanding these mechanisms is vital for safe outdoor activity during winter months.

Subscribe for free to receive new posts and support my work.

* Systemic Vasoconstriction: Cold temperatures trigger the sympathetic nervous system, leading to peripheral vasoconstriction. This increases systemic vascular resistance (SVR) and mean arterial pressure, placing an increased afterload on the heart.

* Pulmonary Vascular Resistance (PVR): Inhalation of cold air can induce localized pulmonary vasoconstriction. For a patient with a resolving PE, this may exacerbate pulmonary hypertension and right ventricular (RV) strain.

* Blood Viscosity: Exposure to cold is associated with hemoconcentration and an increase in blood viscosity. Research indicates that plasma fibrinogen levels often rise in winter, potentially creating a pro-thrombotic environment in susceptible individuals.

* Bronchospasm: Cold air acts as a trigger for airway narrowing, which may be misinterpreted as recurring PE symptoms, causing significant patient anxiety.

3. Phase 1 — Acute Recovery (Months 0–3): Anticoagulation, Movement vs. Rest, and PTS Prevention

The primary objective during the first 90 days is the prevention of clot propagation and the initiation of venous healing.

* Therapeutic Anticoagulation: Immediate initiation of Direct Oral Anticoagulants (DOACs) such as Eliquis is the standard of care to prevent recurrence. Adherence is the single most critical factor in this phase.

* Early Mobilization: Contrary to historical “bed rest” advice, early walking is encouraged as soon as therapeutic anticoagulation is achieved and symptoms allow. This promotes venous return and reduces the risk of new clot formation. I used a desk bike since it was a hell of a winter

* PTS Prevention: The use of medical-grade graduated compression stockings is often recommended to reduce the incidence of Post-Thrombotic Syndrome (PTS), characterized by chronic leg pain and swelling.

* Monitoring: Patients must be educated on “red flag” symptoms, including hemoptysis, sudden worsening of dyspnea, or signs of major bleeding.

4. Phase 2 — Intermediate Recovery (Months 3–6): Re-evaluation, Active Walking, and Post-PE Syndrome Screening

As the risk of acute recurrence diminishes, the focus shifts to evaluating permanent damage and increasing physical capacity.

* Clinical Re-evaluation: Follow-up imaging (e.g., Duplex ultrasound for DVT or CTPA for residual PE) may be conducted to assess clot resolution.

* Post-PE Syndrome Screening: Approximately 50% of PE survivors experience persistent exercise intolerance. Clinicians should screen for chronic thromboembolic pulmonary hypertension (CTEPH) using echocardiography if symptoms persist.

* Structured Walking Program: Transitioning from casual movement to a daily 30-minute brisk walking regimen helps improve cardiovascular efficiency.

* Psychosocial Support: Screening for anxiety and PTSD is essential, as the “fear of recurrence” often peaks during this window.

5. Phase 3 — Long-Term Lung Conditioning (Months 6+): Cardiopulmonary Exercise Testing (CPET) and Aerobic Reconditioning

The final phase aims to restore the patient to their pre-event functional baseline through evidence-based conditioning.

* CPET Evaluation: Cardiopulmonary Exercise Testing (CPET) provides the gold standard for identifying whether exercise limitation is cardiac, pulmonary, or deconditioning-related.

* Pulmonary Rehabilitation: Formal rehabilitation programs involving supervised aerobic and resistance training have shown significant improvements in the 6-minute walk distance (6MWD) for PE survivors.

* Aerobic Reconditioning Protocol: A gradual “Zone 2” heart rate training approach is recommended to improve mitochondrial efficiency without placing excessive strain on the pulmonary vasculature.

* Cold Weather Adaptation: Patients resuming outdoor exercise in winter should use moisture-wicking layers and “cold-weather masks” to pre-warm inhaled air, mitigating PVR spikes.

6. Execution Checklist for Safe Recovery

7. Conclusions & Strategic Recommendations

Recovery from VTE is not merely a waiting game but an active process of vascular and pulmonary remodeling. Cold weather serves as a significant physiological stressor that necessitates cautious activity planning.

A multidisciplinary approach—combining hematological management, cardiological screening for CTEPH, and structured physical rehabilitation—is the most effective strategy for ensuring long-term health and preventing the debilitating effects of Post-PE Syndrome.

8. Limitations & Flagged Uncertainties

While this protocol aligns with current clinical guidelines, several uncertainties remain:

* Individual Variability: The rate of clot lysis varies significantly between patients based on age, genetics, and comorbidities.

* Optimal Duration: The precise duration of anticoagulation (provoked vs. unprovoked) remains a point of clinical debate tailored to individual risk factors.

* Cold Thresholds: There is no universal “safe temperature” for PE survivors; environmental tolerance is highly individualized.

Cited References

* Mayo Clinic: Pulmonary Embolism Diagnosis and Treatment

* NCBI: Physiological Effects of Cold Air on Pulmonary Function

* Cleveland Clinic: Managing Post-Thrombotic Syndrome

* National Blood Clot Alliance: Recovery After a Blood Clot

* NIH/NHLBI: What is Deep Vein Thrombosis?

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit johnhaven10.substack.com

Concrete Wall Of Motivation

If you’re dealing with Long Covid, you know exactly what it feels like to wade through wet concrete—that heavy, impossible-to-shake feeling where just moving, thinking, or even holding a conversation feels like a total uphill battle.

For years, patients have been met with a devastating lack of clinical validation, often told to "just push through" by practitioners who view chronic exhaustion as a failure of moral resilience or a psychological lack of willpower.

If you have experienced what I have when you “try” to explain this every time you see a new doctor, nurse, or specialist—a process that is, in itself, an exhausting labor—you are met with blank, dismissive stares. They look at you like you’re an alien, as if you’ve manufactured the symptoms entirely in your head. It is a soul-crushing experience to have your physical reality treated as a psychological fiction, forcing you to play the role of both patient and defense attorney for your own suffering.

This is Medical Gaslighting

The Impact of Medical Gaslighting:

* Invalidation of Symptoms: Being told that “nothing is wrong” on blood work often leads patients to doubt their own perceptions, despite the severity of their physical limitations.

* The Emotional Toll of Repeated Explanation: Recounting the history of your illness to every new provider acts as a recurring trauma, highlighting the lack of systemic coordination and empathy.

* Stigma vs. Science: The gap between the patient’s lived reality and the dismissive clinical perspective often stems from a lack of research-backed terminology, which is why the recent CAMH findings are so vital.

* The Erosion of Trust: Each dismissive interaction deepens the divide between the medical community and the patient, making it increasingly difficult to seek the care that is genuinely needed.

However, groundbreaking research from the Centre for Addiction and Mental Health (CAMH) has finally identified the "smoking gun" in the brains of Long Covid patients. Utilizing advanced PET imaging, researchers have provided the first direct, in vivo evidence of physical injury to the dopamine system. The frustration you feel is not a character flaw; it is the result of a measurable, structural neurological injury.

Takeaway 1: Your “Willpower” is a Mathematical Calculation

Dopamine is frequently misunderstood as a simple “pleasure chemical,” but in reality, it is the brain’s biological currency for the “Effort-Reward” calculation.

Specifically, a region called:

Ventral Striatum acts as your neurological dashboard. It constantly calculates the ROI (Return on Investment) of any action, weighing the biological cost of movement or thought against the anticipated reward.

When your dopamine levels are healthy, you have the “activation energy” to initiate tasks. When they are depleted, the brain perceives even the smallest chores—like answering a text—as requiring an insurmountable amount of effort.

This is not a choice; it is a mathematical outcome of a damaged system. ”Attempting to overcome this profound physical deficit with ‘willpower’ is biologically equivalent to attempting to drive a vehicle with a shattered transmission by simply pressing harder on the accelerator—it will only result in further systemic damage.

Takeaway 2: The Brain’s “Zombie” Neurons

If you’re enjoying, please share!

Why is this dopamine system failing? Findings from a landmark study by Weill Cornell and Memorial Sloan Kettering reveal a terrifying mechanism:

* SARS-CoV-2 can directly infect human dopamine neurons. While researchers found that only about 5% of these neurons are directly infected, the impact is disproportionately catastrophic because these cells enter a state called cellular senescence.

* infected cells effectively become “zombie neurons.” They stop producing dopamine and begin pumping out inflammatory signals known as SASP (Senescence-Associated Secretory Phenotype).

* This creates a massive “neighborhood effect” —a cloud of inflammation that ruins the function of surrounding healthy tissue.

* This explains the “Aha!” bridge between the studies: while only 5% of cells are “zombies,” their inflammatory signals are likely responsible for the staggering 20% system-wide deficit in dopamine terminals discovered by the CAMH team.

Takeaway 3: The 20% Deficit (Mapping the Damage)

The CAMH PET scans quantified this injury by measuring a 16% to 20% drop in dopamine nerve terminal density. It is crucial to understand that this is “hardware” damage. Many patients think of dopamine as a “fluid” you just need more of (software), but these findings show the “pipes” themselves—the terminals—have been physically degraded. The study found that damage in specific regions of the striatum correlates exactly to the symptoms patients report:

* Ventral Striatum: Linked to motivational collapse and anhedonia (the inability to initiate tasks or feel pleasure).

* Dorsal Putamen: Correlated with physical slowness (bradykinesia) and that “heavy limb” sensation.

* Caudate: Mapped to memory impairment , cognitive sluggishness, and the pervasive “brain fog.”

Takeaway 4: The “Load Equation” is the New Pacing

In a dopamine-deficient brain, exertion is not just tiring—it is cumulative and dangerous.

To avoid Post-Exertional Malaise (PEM), which is a total system crash rather than simple fatigue, patients must manage their energy using a strict biological formula:

Total Load = Physical + Cognitive + Sensory + EmotionalUnder this equation, the Emotional Load —the neuroendocrine cost of a stressful conversation or internal conflict—drains the same “dopamine fuel tank” as a walk or a complex email.

When the sum of these loads exceeds your reduced threshold, the system crashes. Pacing is not a lifestyle choice; it is the essential stabilization of a fragile neurological infrastructure.

Takeaway 5: Why Identity-First Recovery is the Only Path Forward

Because the injury is structural, the focus must shift from “trying harder” to Systems-Based Recovery.

This begins with acknowledging the scope of the crisis. Data from the U.S. Census Bureau Household Pulse Survey shows that the pandemic resulted in over 1.2 million newly disabled adults entering the population by the end of 2021.

This is why identity-first language (identifying as a “Long Covid patient” or a “disabled person”) is a vital tool for advocacy.

It moves the burden of adaptation from the exhausted patient to the system

. If you are neurologically disabled, you are not “failing” to work; the workplace is failing to provide the structural accommodations—such as reduced cognitive loads and sensory-friendly environments—that your biology now requires.

Takeaway 6: The Emerging Pharmacy of Hope

While the damage is significant, science is moving toward targeted repairs. Clinical trials are currently exploring:

* Nutritional Precursors: Supplements like Mucuna pruriens (found in DopaBoost) contain natural L-DOPA, which can bypass metabolic bottlenecks to help the brain synthesize dopamine.

* Bezisterim: A promising candidate that targets neuroinflammation by inhibiting the ERK and NF-κB pathways to suppress TNF-α , potentially halting the “zombie” signals.

* Amantadine: Acts as an NMDA receptor antagonist to prevent “neuronal burnout” and promote the release of remaining dopamine.For those with “super-sensitive” nervous systems, the clinical rule is absolute: Start Low, Go Slow.

Join our community to stay updated on the latest research and recovery strategies—subscribe for free to support this journey.

Conclusion: From Moral Failing to Neurological Reality

Long Covid is a measurable neurological condition, characterized by physical injury to the brain’s motivation center. By dismantling the “willpower” myth, we can finally shift toward a model of care based on biological reality and radical self-compassion.

If we stopped treating energy as a choice and started treating it as a finite biological currency, how would that change the way you treat yourself today?

Resources:

Dopamine & Neurological Injury Research

* First Evidence of Dopamine System Injury in the Brain of Long Covid Patients (CAMH)

* Brain Scans Reveal Dopamine Damage in Long Covid Pointing to New Treatments

* SARS-CoV-2 Can Infect Dopamine Neurons, Causing Senescence

* Long Covid: SARS-CoV-2 Persists in Brainstem Long-Term and Deregulates Neuronal Activity

* Hypothesis: Chronic Inflammation in Long COVID Reduces Dopamine Levels and Contributes to Fatigue and Brain Fog

* Exploring Therapeutic Approaches for Long COVID Neuropsychiatric Sequelae

🔋 Functional Medicine & Mitochondrial Health

* Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness (Institute of Medicine)

* Cellular Bioenergetics is Impaired in Patients with Chronic Fatigue Syndrome

* Cytokine Signature Associated with Disease Severity in ME/CFS Patients

* Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact

* Long-Haul COVID (Neurology Journal)

🧬 Dopamine Precursors & Cognitive Load

* COVID-19 Uniquely Rewires the Brain Compared to the Flu

* Mucuna pruriens in Parkinson’s Disease: A Double-Blind Clinical and Pharmacological Study

* L-DOPA Synthesis in Mucuna pruriens is Regulated by Polyphenol Oxidase

* Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration

* Tyrosine Improves Cognitive Performance and Reduces Blood Pressure During Acute Stress

📉 Post-Exertional Malaise (PEM) & Recovery Pathways

* Cook, D.B. et al. (2017) — ‘Neural consequences of post-exertion malaise in myalgic encephalomyelitis/chronic fatigue syndrome’, Brain, Behavior, and Immunity

* Davenport, T.E. et al. (2019) — ‘Conceptual model for physical therapist management of myalgic encephalomyelitis/chronic fatigue syndrome’, Physical Therapy

* Davis, H.E. et al. (2023) — ‘Long COVID: major findings, mechanisms and recommendations’, Nature Reviews Microbiology

* Komaroff, A.L. and Lipkin, W.I. (2021) — ‘Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome’, Trends in Molecular Medicine

* Systrom, D.M. et al. (2021) — ‘Impaired systemic oxygen extraction in myalgic encephalomyelitis/chronic fatigue syndrome’, Chest

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit johnhaven10.substack.com

When Immune Bodyguards Go Entirely Rogue

Imagine your immune system has a crew of microscopic security guards called mast cells. Under normal circumstances, their job is simple: pull the alarm and trigger temporary inflammation when a real threat—like a dangerous virus or bacteria—shows up.

But sometimes, these security guards drink way too much espresso, completely lose their minds, and start screaming “INTRUDER!” at completely innocent things. A slice of bread, a mild change in room temperature, or just standard daily stress can send them into an absolute meltdown. This chaotic overreaction is known as Mast Cell Activation Syndrome (MCAS), and it is a frequent, uninvited guest in conditions like Long COVID and ME/CFS.

Instead of guessing how to fix an immune system that has completely lost its chill, top clinical immunologists use a systematic, step-by-step framework. Think of it as a four-rung medical ladder designed to transition your body from a state of total panic back to baseline homeostasis. Let’s climb it.

Step 1: Daily Double-Blockade (Antihistamines on a Schedule)

The first line of defense against dramatic mast cells isn’t a rare, experimental miracle drug. It actually starts with standard over-the-counter allergy medications—but optimized to a professional level.

Clinicians recommend using a dual-blockade strategy by combining two different types of antihistamines:

* H1 Blockers: Medications like cetirizine target classic allergy symptoms, itching, flushing, and that miserable post-viral brain fog.

* H2 Blockers: Medications like famotidine are traditionally known as acid-reducers, but they also target histamine receptors in the gut and support overall mast cell stability.

The secret to making Step 1 work is consistency and dosage. Experts emphasize taking these medications on a strict daily schedule and often at higher-than-normal “allergy doses” under a doctor’s care. For instance, a standard escalation protocol might involve taking 10 mg of cetirizine twice a day alongside 20 to 40 mg of famotidine twice a day. This sets up a constant chemical shield to prevent your mast cells from constantly firing their alarm bells

Step 2: Bringing in the Stabilizers (Cromolyn vs. Ketotifen)

If maxing out your basic antihistamines doesn’t completely quiet the crowd, it is time to step up to true mast cell stabilizers. Instead of just blocking histamine after it has already been released into your body, stabilizers act like a physical lock on the mast cell, preventing it from exploding and spilling its inflammatory chemicals in the first place.

The two heavy-hitting stabilizers are selected based entirely on your primary symptoms:

* Cromolyn Sodium (The Gut Specialist): Cromolyn is poorly absorbed by the bloodstream, meaning it stays right where you put it—in the digestive tract. If your mast cells are throwing a tantrum in your stomach, causing constant nausea, severe bloating, or abdominal pain,Cromolyn is usually the first stabilizer layered onto your protocol.

* Ketotifen (The Systemic Warrior): Ketotifen is a dual-action master that acts as both a powerful antihistamine and a systemic mast cell stabilizer. If your symptoms are distributed everywhere—meaning you deal with skin flushing, severe itching, neurological issues, or crazy nighttime histamine spikes that ruin your sleep—Ketotifen is the preferred choice to calm down multiple bodily systems at once.

Step 3: Calling for Backup (Leukotriene Blockers & Adjuncts)

Sometimes, even with antihistamines and stabilizers onboard, a few inflammatory chemicals manage to slip past the perimeter. When mast cells degranulate, they don’t just dump histamine; they also produce inflammatory molecules called leukotrienes.

When you hit Step 3, doctors introduce leukotriene receptor antagonists (such as montelukast). Think of these as specialized interceptors. They are incredibly effective at stopping those rogue chemicals before they can interact with your tissues, making them a standard addition for patients dealing with respiratory symptoms like wheezing, asthma-like flares, or persistent chest tightness. Other unique adjuncts, like aspirin, can also be layered in here by specialists if specific inflammatory markers (like prostaglandin D2) are heavily elevated.

Step 4: The Big Guns (Biologics for Stubborn Cases)

What happens if you have climbed the first three rungs, tracking your doses perfectly, but your immune system is still acting like an angry toddler in a toy store? You reach the top of the ladder: biologics.

For highly refractory, severe cases where standard oral medications aren't quite cutting it, monoclonal antibodies are next

* omalizumab (commonly known as Xolair) : This is an advanced, targeted injection therapy that specifically binds to and neutralizes IgE antibodies—the keys that turn on mast cell reactions. While it is reserved as a later-line rescue therapy rather than a first option, clinical data shows it can dramatically lower symptom burdens and stop recurrent, severe allergic reactions in its tracks

The Long COVID and ME/CFS Overlap

If you are currently navigating the exhausting maze of Long COVID or ME/CFS and wondering why your body suddenly reacts violently to minor triggers, you are not imagining things.

Emerging immunological research confirms that long-term post-viral conditions frequently trigger a clinical syndrome that is practically indistinguishable from classic MCAS. Because the underlying biological wiring is identical, top complex care clinics are successfully utilizing this exact step-by-step treatment ladder to help post-viral patients systematically cool down their hyperactive immune systems. The universal golden rule across all Steps? Start low, titrate up slowly, and let the science stabilize the system.

Key Takeaways

* Systematic Eviction: MCAS and post-viral immune overreactions are best treated using a logical, stepwise medical ladder rather than guessing at random therapies.

* The Baseline Blockade: Step 1 requires optimizing both H1 and H2 antihistamines on a strict schedule at higher-than-allergy doses to build a stable foundation.

* Targeted Stabilizers: Mast cell stabilizers physically prevent cell explosions; Cromolyn works beautifully for dominant gut issues, while Ketotifen targets skin and brain symptoms.

* Advanced Clearance: Later steps introduce leukotriene blockers for respiratory chest tightness, eventually moving to targeted biologics like omalizumab for severe, stubborn cases.

FAQs

What is the main difference between an antihistamine and a mast cell stabilizer?

Think of antihistamines as a cleanup crew that mops up water after a pipe bursts; they block histamine after it is already loose in your system. Mast cell stabilizers act like a structural reinforcement on the pipe itself, preventing it from bursting open in the first place.

Can I just skip to Step 4 if my symptoms are incredibly severe?

In clinical practice, immunologists strongly prefer climbing the ladder sequentially. First-line treatments like optimized antihistamines and stabilizers are highly effective, safer for long-term daily use, and establish the foundational biological control needed before introducing heavy clinical therapies like biologics.

How do I know if my Long COVID has turned into an MCAS phenotype?

If your post-viral symptoms include random spells of skin flushing, dermatological itching, hives, unprovoked brain fog, abdominal pain, bloating, or wheezing triggered by basic foods, scents, or temperature changes, your mast cells may be driving your symptoms

If you’re ready to stop feeling like your immune system is a toddler with a megaphone, you might want to look into Quercetin, Luteolin, Buffered Vitamin C, and DAO enzymes. I’ve attached some info cards—or, as the cool kids in the tech world apparently call them, “visuals”—so you can actually see what you’re putting in your body.

And for the record, this isn’t just me playing internet scientist; I’ve lived through this chaos, and I can confirm that these actually work. It turns out that listening to the clinical research and getting your biology in check is slightly more effective than just hoping for the best.

Call to Action

Your immune system shouldn't feel like a hostile environment. Healing from MCAS and chronic post-viral inflammation requires strategy, patience, and a step-by-step game plan.

Have you noticed a difference with a strict H1/H2 routine?

Leave a comment below and share your thoughts!

Don't forget to share this guide with anyone fighting the chronic inflammation battle, and subscribe to our newsletter for more sharp, science-backed breakdowns of the human body.

Please Share to Bring Awareness to the Silently Suffering !

Resources

The Treatment Blueprint: Core Medical Literature

* Pharmacological Treatment Options for Mast Cell Activation and Mastocytosis

Valent, P., Akin, C., Arock, M., et al. (2016). Current Treatment Options in Allergy.

Read the full paper on PubMed Central.

* Diagnosis and Management of Mast Cell Activation Syndrome

Valent, P., Akin, C., Escribano, L., et al. (2025). Allergy.

Access the advance online publication.

* Omalizumab Therapy for Mast Cell–Mediator Symptoms in Patients with Mastocytosis and MCAS

Torrente, F., Piazza, R., Ricci, C., et al. (2019). Allergy.

Read the study details on PubMed.

* Effectiveness and Safety of Antihistamines Up to Fourfold or Higher Dosage: A Systematic Review

Zuberbier, T., Aberer, W., Asero, R., et al. (2017). Journal of the European Academy of Dermatology and Venereology.

Read the systematic review.

Clinical Protocols & Escalation Guides

* Mast Cell Activation Syndrome: A Practical Escalation Protocol (ESSI)

International EDS / Endocrinology Society. (2026).

View the ESSI protocol.

* A Practical Approach to Complex Long COVID & ME/CFS

Bateman Horne Center. (2025).

Download the clinical PDF guide.

* Antihistamines for MCAS: H1 and H2 Blockers in Mast Cell Disease

RTHM Clinic. (2026).

Read the H1/H2 breakdown on RTHM.

* Cromolyn vs. Ketotifen and Other Antihistamines for MCAS

EDS Clinic. (2025).

Compare stabilizer options at EDS Clinic.

* Treatments for MCAS & Mast Cell Disease

EDS Clinic. (2025).

Review the complete treatments breakdown.

* Mast Cell Activation Syndrome (MCAS) & Eating Disorders

Gaudiani Clinic. (2022).

Explore the complex overlap on the Gaudiani blog.

Patient Advocacy & Foundations

* Medications to Treat Mast Cell Diseases

The Mast Cell Disease Society (TMS). (2025).

Access the TMS master medication list.

* Treatment of Mast Cell Disease

Mastocytosis Society Canada. (2025).

Review patient guidelines at Mastocytosis Canada.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit johnhaven10.substack.com

The Brain on Fire Myth Debunked

For a long time, the prevailing theory was that Long COVID meant your brain was trapped in a state of permanent, widespread swelling. It was an alarming narrative that left many people feeling like their gray matter was constantly on fire. However, a groundbreaking piece of research detailed in Finnish Brain Study LC..

Using advanced PET imaging, researchers in Finland looked for activated glial cells—the classic markers of neuroinflammation—in people with Long COVID, healthy individuals, and multiple sclerosis patients. The results were unexpected: the global inflammation signal in Long COVID patients did not differ from healthy controls. In fact, it was actually lower than the inflammation found in the white matter of multiple sclerosis patients.

While inflammation is present and slightly higher during the first 16 months after an infection, the data shows that it tends to subside over time. Widespread, chronic brain swelling is not the universal explanation for long-term symptoms.

The Limbic System: Your Brain’s Dramatic Alarm Clock

If your brain isn’t actively swollen years down the line, why do you still feel like you are running on a broken battery? The answer lies in specific stress and emotion hubs inside your head: the hippocampus, the amygdala, and the thalamus. Collectively, these make up the limbic system.

The Finnish study found that lower quality of life, anxiety, and depression scores strongly tied to a higher imaging signal in these exact threat-detection zones.

The Vicious Cycle of Central Sensitization

This structural activity points to a phenomenon known as central or limbic sensitization. Think of your nervous system like a high-tech home security system. The acute viral infection was a real break-in. But even though the burglar is long gone, the alarm system is now so glitchy and sensitive that a passing shadow sets off the sirens.

When these emotional and threat-monitoring structures stay sensitized, they drive a state of hypervigilance. Your brain amplifies internal body sensations, disrupts your sleep, and triggers an overreactive stress response. This is completely biological, not just psychological. This chronic hyper-alert state physically alters your neurotransmitters, network connectivity, and neuroimmune signaling, directly shaping your fatigue, pain, and cognitive issues.’

When the Autonomic Wiring Glitches

When your brain’s alarm system stays stuck on high alert, the physical fallout is felt throughout the entire body. The autonomic nervous system—the automatic pilot that handles your heart rate, blood pressure, and digestion—begins to misfire.

This explains why syndromes like POTS are incredibly common in Long COVID recovery. Patients regularly experience dizziness, wild blood pressure swings, an abnormally fast heart rate upon standing, and gut issues.

Thanks for reading! This post is public so feel free to share it.

The Graded Exercise Trap

Here is where standard medical advice often backfires. A massive 75% of people with Long COVID report that physical activity actively worsens their symptoms. This is called post-exertional symptom exacerbation.

A review of 32 different exercise studies confirmed that this profound exhaustion isn’t just because a patient is out of shape. Instead, the blame falls on endothelial dysfunction, blood vessel lining issues, and impaired peripheral oxygen extraction. Pushing through the fatigue with aggressive, generic exercise routines can damage the system further, which is why modern guidelines explicitly demand pacing over traditional workouts

The Reboot Protocol: Retraining Your System

Because Long COVID functions as a systems-level disorder combining immune, vascular, and nervous system pathways, late-stage anti-inflammatory drugs might not be the golden ticket. Instead, recovery requires tools that target autonomic and limbic regulation to teach the nervous system that it is safe again.

1. Resonant Breathing

Slow, paced nasal breathing at a rate of five to seven breaths per minute has been shown to stabilize autonomic function. In a clinical pilot program, practicing this resonant breathing for just 10 minutes twice a day yielded measurable reductions in symptom severity, better sleep, and lower functional disability.

2. Autonomic Conditioning and Pacing

Rebuilding physical tolerance requires strict stabilization before exertion. This means focusing on supine (lying down) or seated strength work rather than upright cardio, incorporating long breathing rests between movements, and enforcing hard stop rules the moment a symptom flares.

3. Vagus Nerve Stimulation

Small pilot studies utilizing transcutaneous vagus nerve stimulation have shown promise in reducing chronic pain and fatigue. While still considered experimental, gently stimulating the vagus nerve helps modulate systemic inflammation and coaxes the body out of a sympathetic fight-or-flight state.

Ultimately, recovery is about changing the internal narrative from a body that is permanently damaged to a nervous system that is highly adaptable and ready to be retrained.

Key Takeaways

* Long COVID is not caused by permanent, widespread brain inflammation.

* Symptom severity directly correlates with overactivity in the limbic system—the brain’s threat and stress networks.

* Autonomic dysfunction, including POTS and poor oxygen delivery to tissues, explains why standard exercise makes 75% of patients feel worse.

* Successful recovery protocols focus on nervous system regulation through slow resonant breathing, strict pacing, and seated conditioning.

FAQs

Does the Finnish study mean Long COVID is a mental issue?

No.

Limbic sensitization is a physical, biological state. The overactivity in these brain regions changes real physical pathways, modifying neurotransmitters and neuroimmune signaling to produce genuine physical exhaustion, pain, and cognitive impairment.

Why does physical activity make me feel worse?

Long COVID impairs how your cells extract oxygen and compromises your blood vessel function. Because your autonomic nervous system is dysregulated, pushing your body too hard triggers severe symptom flare-ups rather than building fitness.

How does resonant breathing actually help?

Breathing slowly at five to seven breaths per minute acts as a manual override for your nervous system. It stimulates vagal tone, shifts your body from a stressed state into a resting state, and helps recalibrate heart rate variability.

Call to Action

Leave a comment below sharing which recovery strategy you are focusing on this week, and subscribe to the newsletter to get the latest, fluff-free health science updates delivered straight to your inbox. on this week, and subscribe to the newsletter to get the latest, fluff-free health science updates delivered straight to your inbox.

References & External Resources

Tuomaala J, Airas L, et al. Association between post‑COVID‑19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study. Journal of Neurology, 2026.Press summary (University of Turku): https://www.utu.fi/en/news/press-release/brain-inflammation-is-unlikely-to-explain-persistent-long-covid-symptoms [utu]

ScienceDaily summary of Tuomaala et al. Brain inflammation is unlikely to explain persistent Long COVID symptoms. https://www.sciencedaily.com/releases/2026/05/260527023206.htm (sciencedaily.com in Bing) [sciencedaily]

Omdal R, Lenning OB, Jonsson G, et al. Long COVID: assessment of circulating markers suggests no cerebral neuronal damage, neuroinflammation or systemic inflammation – a controlled study. (Stavanger University Hospital group)Summary discussion: https://www.s4me.info/threads/long-covid-assessment-of-circulating-markers-suggests-no-cerebral-neuronal-damage-neuroinflammatio (s4me.info in Bing) [s4me]

Hugon J, Msika EF, Queneau M, et al. Long COVID brain fog: a neuroinflammation phenomenon? Reviews neuroinflammation mechanisms in Long COVID cognitive dysfunction.https://pmc.ncbi.nlm.nih.gov/articles/PMC9914477/ (pmc.ncbi.nlm.nih.gov in Bing) [pmc.ncbi.nlm.nih]

Guedj E, Campion JY, Dudouet P, et al. 18F‑FDG brain PET hypometabolism in patients with Long COVID. EJNMMI, 2021.https://pmc.ncbi.nlm.nih.gov/articles/PMC7837643/ (pmc.ncbi.nlm.nih.gov in Bing) [pmc.ncbi.nlm.nih]

Peluso MJ, Spudich S, et al. Neuroinflammation in post‑acute sequelae of COVID‑19 (PASC) as assessed by 11C‑PBR28 PET correlates with symptoms. Study overview: https://recovercovid.org/publications/neuroinflammation-post-acute-sequelae-covid-19-pasc-assessed-11cpbr28-pet-correlates (recovercovid.org in Bing) [recovercovid]

Chun JY, Park H, et al. Neuroimmune pathophysiology of Long COVID. Comprehensive review of immune, autonomic, and neuroinflammatory mechanisms.https://pmc.ncbi.nlm.nih.gov/articles/PMC12247276/ (pmc.ncbi.nlm.nih.gov in Bing) [pmc.ncbi.nlm.nih]

The Dysautonomia Project. Long COVID autonomic dysfunction overview. Evidence summary on dysautonomia, autonomic instability, and related mechanisms.https://thedysautonomiaproject.org/long-covid-autonomic-dysfunction/ (thedysautonomiaproject.org in Bing) [thedysautonomiaproject]

Putrino D, et al. Autonomic dysfunction and rehabilitation in Long COVID. Includes analysis of autonomic rehab and breathing‑pattern interventions.Secondary commentary: https://www.healthrising.org/blog/2024/01/12/putrinos-autonomic-rehabilitation-program-for-long-covid-does-it-work/ (healthrising.org in Bing) [healthrising]

Putrino D, Meo Health collaborators. Resonant breathing improves self‑reported symptoms and wellbeing in people with Long COVID. Frontiers in Rehabilitation Sciences, 2024.PubMed: https://pubmed.ncbi.nlm.nih.gov/39071772/ (pubmed.ncbi.nlm.nih.gov in Bing

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit johnhaven10.substack.com

Long COVID Isn’t Just One Thing (It’s a Terrible Variety Pack)

If you feel like Long COVID is a shapeshifting monster that no one can quite pin down, you are entirely right. Long COVID looks less like a single illness and much more like a few overlapping “syndromes” that share the same starting line but run down completely different biological pathways.

According to the latest data from the RECOVER initiative, scientists are finally mapping these chaotic pathways and running targeted trials to see which treatments actually work.

Whether you develop Long COVID comes down to three main ingredients: your baseline health before the infection (like your sleep quality), the severity of the acute infection, and what lingering damage or viral traces are left behind after the initial battle.

From this chaotic mix, researchers have identified three distinct Long COVID “phenotypes”. Let’s break them down without the medical jargon.

Phenotype 1: The “Viral Hangover” (Viral Persistence)

Imagine hosting a terrible houseguest who finally leaves but hides their dirty laundry in your air vents. That is the viral persistence phenotype. In this pattern, the virus never fully leaves the body, or it leaves behind enough debris to constantly annoy your immune system.

* Hide and Seek: Studies show that viral genetic material or proteins can hide out for months in the gut, lymph nodes, and brain.

* The Slow Burn: These lingering viral fragments act like a constant alarm bell for your immune system, keeping inflammation simmering.

* The Symptoms: This constant immune battle leads to exhausted T-cells and sometimes reactivates dormant viruses like Epstein-Barr. It can also cause sticky platelets and micro clots, which starve your tissues of oxygen. If you are dealing with crushing fatigue, brain fog, and massive energy crashes, you might be stuck with this viral hangover.

Phenotype 2: The “Wiring Glitch” (Autonomic POTS)

If Phenotype 1 is a squatter, Phenotype 2 is an electrical fire. Here, the core problem is a mis-calibrated autonomic nervous system, often accompanied by nerve fiber damage.

* The Sensation: Your heart rate shoots through the roof just from standing up. You feel lightheaded, near-faint, and washed out, as if your body has entirely forgotten how to operate its own automatic stability controls.

* The Biology: This is driven by small fiber neuropathy—damage to the tiny nerves carrying autonomic signals. Many patients also develop autoantibodies that attack the receptors controlling blood vessels and heart rate.

* The Adrenaline Fix: Because vascular tone is poor, the body leans heavily on adrenaline to compensate, leaving you in a constant, exhausting state of “fight or flight”.

Phenotype 3: The “Primed Immune System” (Sleep-Linked Vulnerability)

Thanks for reading! Subscribe for free to receive new posts and support my work.

This one starts before you even catch the virus. In the RECOVER data, over half of the people who met the criteria for likely Long COVID reported having sleep disturbances before they were ever infected.

* The Glucocorticoid Resistance Twist: Your body uses glucocorticoids as built-in anti-inflammatory signals to calm things down. However, in people with pre-existing sleep problems, their immune cells become less responsive to these calming signals after a COVID infection.

* The Hair Trigger: Basically, poor sleep puts your immune system on a hair trigger. When the virus arrives, the inflammatory response is excessively loud and fails to switch off, making you highly susceptible to getting stuck in a Long COVID loop.

Poking the Bear: How the RECOVER Trials Are Fighting Back

The RECOVER program isn’t just taking notes; they are running experiments to purposefully nudge these specific pathways and see what breaks the cycle.

* RECOVER-VITAL: This trial is tackling the viral reservoir. Patients are given extended courses of the antiviral drug Paxlovid to see if aggressively attacking lingering viral fragments will calm the immune system and relieve fatigue and brain fog.

* RECOVER-AUTONOMIC: This targets the “wiring glitch”. Patients with POTS are randomized to receive non-drug care, heart-rate-lowering medication (ivabradine), or immune-targeted treatments (intravenous immunoglobulin) to see what actually fixes the nervous system misfire.

The future of Long COVID treatment isn’t a one-size-fits-all magic pill. It is about finding exactly which biological pathway went rogue in your body, and deploying the exact right counter-measure.

Key Takeaways

* Long COVID is not a single disease; it consists of overlapping syndromes driven by different internal pathways.

* Phenotype 1 (Viral Persistence): Lingering viral fragments in the gut or tissues keep the immune system constantly inflamed, causing severe fatigue and brain fog.

* Phenotype 2 (Autonomic POTS): Nerve damage and autoantibodies cause the body’s automatic control systems to misfire, leading to rapid heart rate and dizziness upon standing.

* Phenotype 3 (Sleep-Linked): Pre-existing sleep issues can cause “glucocorticoid resistance,” meaning the immune system loses its ability to turn off inflammation after infection.

* Targeted clinical trials, like RECOVER-VITAL and RECOVER-AUTONOMIC, are currently testing specific medications like Paxlovid and ivabradine to treat these exact mechanisms.

FAQs

What exactly is a “viral reservoir”?

A viral reservoir occurs when genetic material or proteins from the virus hide out in your body’s tissues (like the gut or lymph nodes) long after the acute infection has passed.

Why does my heart race when I stand up after having COVID?

This is a hallmark of the Autonomic POTS phenotype. Damage to small nerve fibers and autoimmune responses cause your body’s automatic blood flow and heart rate controls to glitch, leading to a massive spike in heart rate when you change posture.

Can fixing my sleep cure my Long COVID?

While fixing your sleep post-infection is crucial, the RECOVER data specifically highlights that pre-existing sleep problems create a vulnerability that makes your immune system overreact. Addressing sleep now is a great foundation, but you may still need targeted interventions for the lingering inflammation.

Call to Action

The science is finally catching up to the symptoms.

Which of these three phenotypes sounds the most like what you or a loved one are experiencing?

Drop a comment below and let’s get the discussion going! Don’t forget to share this post to help demystify Long COVID for others, and subscribe to our newsletter for more no-nonsense breakdowns of the latest health science.

SOURCES

* Nature Reviews Microbiology review on Long Covid mechanisms viral persistence, immune dysregulation, microclots.

* RECOVER VITAL trial descriptions and protocol extended Paxlovid for Long Covid.

* RECOVER AUTONOMIC design and early ivabradine results targeting POTS in Long Covid.

* RECOVER pathobiology sleep disturbance and glucocorticoid resistance before Long Covid.

* Studies on small fiber neuropathy and autonomic dysfunction in Long Covid.

* Epidemiology of sleep disorders, Covid outcomes and Long Covid risk.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit johnhaven10.substack.com

Listen to the cinematic narration of this story — 2 minutes that will change how you see GLP‑1

The GLP-1 Mirror: What the Weight-Loss Drug Revolution Reveals About Who We Are

For decades, the cultural narrative around weight loss has been a grueling tale of sheer willpower, boiled chicken breast, and relentless physical suffering. Then came the GLP-1 receptor agonists.

Medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have triggered one of the most massive shifts in modern public health. Originally developed for Type II diabetes, these drugs mimic natural hormones to regulate blood glucose and suppress appetite. By slowing gastric emptying and directly communicating with the central nervous system, they effectively silence the mental chatter known as “food noise”. The clinical results are staggering: patients taking semaglutide showed a mean body weight reduction of 14.9% over 68 weeks.

As a fitness coach with a background in psychology, I know exactly what happens when your physical reality changes faster than your mental state. When I had to rebuild my own body from a skeletal 114 pounds back to 198 pounds, the physical rehabilitation was brutal—but the mental warfare was the actual main event. You can you don’t upgrade the psychological software, the system eventually crashes.

With an estimated 12% to 18% of U.S. adults having used or currently using a GLP-1 medication, we are moving past the medical novelty phase and straight into a profound psychological void. If a weekly injection does the heavy lifting of a caloric deficit, who exactly gets the credit for the transformation?

The Sociology change the biological hardware, but if of the “Cheat Code”

Despite treating obesity as the complex metabolic disease it actually is, people utilizing GLP-1s are facing a massive social backlash. Society loves a comeback story, but it demands that you suffer for it.

Sociologists attribute this to “effort moralization”—a deep-seated cognitive bias where we instinctively equate physical or mental suffering with moral value. Because these drugs bypass the visible, exhausting struggle against hunger, society frequently dismisses the results as “taking the easy way out”.

The judgment is harsh and empirically proven:

* In controlled studies, people who lost weight using GLP-1s were viewed significantly more negatively than those who lost the exact same amount of weight through traditional diet and exercise.

* Observers assigned fewer positive character traits (like honesty or competence) to GLP-1 users.

* Shockingly, participants routinely rated GLP-1 users more negatively than individuals who attempted no intervention at all and remained obese.

* White women using these medications face particularly high levels of social rejection, blame, and fatphobia, often accused of taking a “shortcut”.

This creates a brutal double bind: you are stigmatized for carrying the weight, and subsequently stigmatized for the medical method you choose to lose it.

The Psychological Void: Identity Lag and Imposter Syndrome

When your physical body shrinks at an accelerated, pharmacological rate, your brain requires a massive amount of time to catch up. This creates a cognitive dissonance known as “identity lag”. For years, a person might have built their entire routine and self-concept around being a “struggling dieter”. When a drug abruptly removes that struggle, it leaves a terrifying vacuum.

* Body Dysmorphia: As the weight drops, the reflection in the mirror feels completely alien and disconnected from the person’s internal self-representation.

* The Grief of Sustenance: Food is heavily tied to emotional regulation and social connection. When the desire for comfort food or celebratory drinks is chemically eradicated, patients often report feeling emotionally “flat” and must actively grieve the loss of these coping mechanisms.

* The Atrophy of Agency: Facing accusations of “cheating,” patients internalize the stigma and develop imposter syndrome. They begin to wonder if they are just passive passengers in their own bodies, which poses an existential threat to long-term health if the medication is ever paused or loses efficacy.

The Fix: Identity-Based Motivation (IBM)

To survive the psychological fallout of the GLP-1 era, we have to stop focusing on the math of calories and start focusing on the architecture of identity. Dr. Daphna Oyserman’s Identity-Based Motivation (IBM) theory provides the perfect blueprint.

IBM theory suggests that willpower isn’t a gas tank you empty; it’s driven by which version of your identity is currently at the wheel.

* The Old Way (Outcome-Based): You focus on a specific external goal (”I want to lose 30 pounds”) and rely on sheer willpower to endure a miserable, restrictive diet. When willpower burns out, you relapse.

* The New Way (Identity-Based): You focus on an internal self-concept (”I am a healthy person”). Your internal dialogue shifts from forced restriction (”I can’t eat that”) to natural alignment (”I fuel my body with nutritious food”).

When you operate from an aligned identity, you view difficulty not as an impossible stop sign, but as proof of importance—the classic “no pain, no gain” mindset. The medication gives you the biological breathing room; it’s up to you to build the new identity in that quiet space.

Operationalizing the Shift: The FiT iQ Methodology

Understanding the psychology is great, but executing it requires the right tools. The FiT iQ ecosystem was built precisely to bridge the massive gap between physical conditioning and deep mental evolution.

Here is how we turn abstract psychology into concrete reality:

* The 100% Method: We structurally mandate mental fitness. Our proprietary training protocol allocates 50% to physical conditioning, 20% to nutrition, 10% to injury prevention, and a non-negotiable 20% strictly to mental training and cognitive conditioning.

* Advanced BIA Technology: Standard bathroom scales only measure gravity, which crushes motivation. The FiT iQ Body Scanner uses eight BIA sensors to capture 56 distinct body metrics in under 60 seconds. By tracking granular data like localized fat distribution, visceral fat, and muscle mass, you get undeniable proof of your progress even if your total weight stalls..

* FitIQ Education: Because the industry needs better guides, we provide globally recognized qualifications to train coaches in relapse prevention, the gut-brain connection, and the realities of modern metabolic health.

You can inject a compound to alter your biology, but lasting vitality requires deliberate, strategic psychological evolution. The ultimate determinant of your health isn’t what changes your physical body—it’s what permanently redefines your mind.

Key Takeaways

* The “Food Noise” Mute Button: GLP-1 drugs work incredibly well by slowing gastric emptying and silencing neurological hunger signals, but they trigger a massive psychological shift.

* The “Cheat Code” Stigma: Society unfairly punishes GLP-1 users due to “effort moralization,” believing that health must be earned through visible suffering.

* Identity Lag is Real: Your body changes faster than your brain can process, leading to body dysmorphia, emotional flatness, and imposter syndrome.

* Build an Identity, Not Just a Deficit: Using Identity-Based Motivation shifts your mindset from relying on finite willpower to taking actions that naturally align with a “healthy person” self-concept.

* Measure What Matters: Ditch the standard scale. Utilizing advanced BIA scanning technology provides granular proof of your internal changes, reinforcing your new identity.

Sources:

theguardian.com

‘I lost so much weight, my husband thought I was terminally ill’: why do people lie about taking Ozempic? - The Guardian

dornsife.usc.edu

Identity-Based Motivation and Health - USC Dornsife

rcgd.isr.umich.edu

Identity-Based Motivation - Research Center for Group Dynamics

journals.uni-lj.si

Beyond Diet & Exercise: Paul MacNeill’s True Weight Loss Secret. [qkjnrz]

resources.healthgrades.com

6 Common Myths About GLP-1 Medications for Weight Loss - Healthgrades Health Library

neurosciencenews.com

Oral GLP-1 Is Here. Have Credit Markets Caught Up? - Neuberger Berman

gardner.law

FDA Escalates Enforcement Against Compounded GLP-1 Marketing - Gardner LaW

fda.gov

FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

raps.org

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit johnhaven10.substack.com

Learn More Here

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit johnhaven10.substack.com